Stroke. Sequelae of stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: Caffeine, 200 mg capsule, oral, twice a day in 1 month. Intervention 2: Flour, 200 mg capsule, oral, twice a day in 1 month. Intervention 3: Transcranial magnetic stimulation, 20 pulse
Treatment - Drugs
Placebo
Caffeine, 200 mg capsule, oral, twice a day in 1 month
Flour, 200 mg capsule, oral, twice a day in 1 month
Transcranial magnetic stimulation, 20 pulses, 10 Hz, 2 seconds, three times a week in 1 month
Non-stimulating waves of transcranial magnetic stimulation, 20 pulses, 1 Hz, 2 seconds in 1 month
Sponsors
Vice-chancellor for Research of Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1) Age 18 to 85 years 2) Motor impairments after stroke 3) Scores 15 to 55 in Fugl-Mayer test Exclusion Criteria: 1) Severe major depression 2) Severe motor impairment 3) Other neurodegenerative disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor impairments. Timepoint: Before treatment and one month after treatment. Method of measurement: Fugl-Meyer test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disability. Timepoint: 1 month. Method of measurement: Barthel test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojtaba Keshavarz
Shiraz Neuroscience Research Center
Outcome results
None listed